–
Статьи в журналах
-
- 2021 The effectiveness and safety of eribulin therapy in HR-positive HER2-negative metastatic breast cancer post-CDK4/6 inhibitor therapy in Russian clinical practice
- Kolyadina Irina Vladimirovna, Bolotina Larisa, Zhukova Lyudmila, Vladimirova Liubov Yu, Sultanbaev Alexander, Karabina Elena, Ganshina Inna, Ovchinnikova Elena, Kolyadina Irina Vladimirovna, Antonova Galina, Volkonsky Mikhail, Kolokolov James, Zueva Elena, Akopyan I., Fadeeva Natalia, Evstigneeva Irina, Orlova Svetlana, Vasilevskaya Anna, Shalaeva Oxana, Shirokova Oxana
- в журнале Journal of Clinical Oncology, издательство American Society of Clinical Oncology (United States), том 39, № 15_suppl, с. e13035-e13035 DOI